contact[at]op2lysis.com

pilelabs
  • The company
  • The Technology
  • Products
  • Indications
  • News
  • Contact
  • Français

Daily Archives: 24 January 2023

  1. Home
  2. 2023
  3. January
  4. 24
  • Jerôme Parcq
  • January 2023
  • Corporate
Retrospective – 2022 in a nutshell

In 2022, Op2Lysis has taken on a new dimension with the support of the EIC Accelerator in Europe, Bpifrance in France and Win4Company in Belgium. The following sections describe the company’s progress on corporate, technical and  regulatory fronts. We would also like to take this opportunity to wish a happy new year 2023 to all […]

Read More

Articles récents

  • Nominated for the GALIEN USA 2023 award “Best Startup”
  • Op2Lysis is a silver sponsor of the WICH 2023 conference and will have the opportunity to give two oral presentations to an expert audience  in cerebral haemorrhage
  • New support from Bpifrance for €1.5M, covering the GMP production of the Drug Substance OptPA, has been obtained
  • Retrospective – 2022 in a nutshell
  • The EIC Accelerator grant agreement has been signed by the European Innovation Council and provides €2.5M support to the O2L-001 development programme

Archives

  • October 2023
  • September 2023
  • July 2023
  • January 2023
  • December 2022
  • September 2022
  • April 2022
  • January 2022

Catégories

  • Corporate
  • Event
  • Press Release
gym-footer-logo

Biotechnology company that researches and develops innovative medicines

Supported by
europe
bpi
wallonie

SItemap

  • Contact
  • home
  • Indications
  • Legal Notice
  • News
  • Products
  • The company
  • The Technology

Recent Posts

Nominated for the GALIEN USA 2023 award “Best Startup”
October 12, 2023
Op2Lysis is a silver sponsor of the WICH 2023 conference and will have the opportunity to give two oral presentations to an expert audience  in cerebral haemorrhage
September 14, 2023

Contact

  • FRANCE: 117 avenue Victor Hugo, 92100 Boulogne-Billancourt, France BELGIUM: Légia Park, Boulevard Patience et Beaujonc, 3, 4000 Liège, Belgium

Op2Lysis © 2022 All Rights Reserved – Legal notice – web agency : Bridge Communication